Longevity & wellbeing

MOTS-c

Mitochondrial peptide for energy and metabolic resilience.

Medical guidance
Clinical review required

This listing is educational only. It is not offered for ordering, and no supply can be reserved here.

Find your care

Availability and treatment are not guaranteed.

vidameds

Compounded medications are not FDA-approved.

Understanding MOTS-c

Know the treatment.
Ask better questions.

MOTS-c is a mitochondrial-derived peptide investigated in metabolism and aging research. It is not an FDA-approved treatment.

How it works

Preclinical research examines cellular energy and metabolic signaling. These mechanisms do not establish clinical benefits or longer life in humans.

Safety & suitability

Safety, effective dosing, interactions, and long-term effects are not established. Unapproved injectable products may pose additional quality and immune-response risks.

Bring to your care conversation

  • Which evidence-based approaches address my metabolic health concerns?
  • What is the exact formulation, and which approved alternatives should I consider?
  • What side effects, interactions, and follow-up should we discuss before a decision?

Research, in perspective

What the evidence says.

Preclinical research

Mitochondrial research—not proven longevity.

MOTS-c is a mitochondrial-derived peptide discussed in metabolic research. Measurements of the body's own MOTS-c or studies of analogues do not establish benefits of the injected product.

FDA reports that it has not identified human exposure data for drug products containing MOTS-c and identifies impurity and immune-response concerns. Anti-aging and metabolic benefits are not established.

Read the sources

Evidence at a glance

What has been studied

Preclinical biology and research on naturally occurring peptides.

What remains unknown

Therapeutic human benefit and safety of injected MOTS-c.

What this means for you

Evidence must match the ingredient, formulation, and condition. A biological mechanism is not a guaranteed clinical result.

01

Mitochondrial peptide biology

02

Experimental metabolic signaling

03

Injectable clinical benefit remains unestablished

Sources & further reading

  1. 01FDA: Compounding substances with potential significant safety risks
  2. 02FDA: Understanding the risks of compounded drugs

Research context is educational and does not confirm the safety, effectiveness, or availability of the pictured product.

The Vida Meds difference

Connected care.
Personal at every step.

A nationwide provider network. Direct pharmacy pricing. A team you can reach.

200+

Licensed providers

A nationwide network of licensed clinicians.

50 states

Nationwide care

Our provider network spans all 50 states.

Direct pharmacy

Pricing

Direct Pharmacy Pricing for your treatment.

Overnight

ColdChain Shipping

Temperature-controlled shipping for medications that require it.

24-hour

Customer support

Support for your questions, around the clock.

Direct access

Patient portal

Connect with your provider and dedicated care team.

Treatment eligibility, medication availability, and shipping arrangements depend on clinical review and the prescribed medication. Customer support is not emergency care; call 911 for a medical emergency.

Couple hiking on a green coastal trail

Beyond the medication

More life in your years.

Build a foundation for long-term wellbeing through movement, sleep, nutrition, and preventive care. Understand emerging peptide research without the hype.

Explore longevity & wellbeing

Continue exploring